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INTRODUCTION
Obesity is one of the most important risk factors for 
the development of type 2 diabetes (Colditz et al., 
1990). Insulin sensitivity can be modulated by dif-
ferent lifestyle factors, and the quality of dietary fat 
seems to be an important one (Vessby et al., 2001; 
Allen et al., 2003). 
Epidemiological  studies  in  humans  based  on 
dietary  questionnaires  have  generally  found  a 
positive  association  between  intake  of  saturated 
fatty acids (SFA) and risk of diabetes (Feskens and 
Kromhout, 1990; Salmeron et al., 2001). However, 
data on relationships between polyunsaturated fatty 
acid (PUFA) intake and insulin sensitivity are less 
clear  (Feskens  et  al.,  1995;  Salmeron  et  al.  2001). 
Dietary fat intake is difficult to estimate, and the 
amount of different fatty acids in the phospholipids 
of serum or cell membrane appears to be a more 
objective marker of dietary intake than dietary ques-
tionnaire measurements (Rivellese et al., 2002). The 
concentrations of essential n-6 and n-3 PUFAs in 
cell membranes or body tissues are highly correlated 
with dietary intake (Ma et al., 1995) and blood cell 
membrane composition is an objective biomarker 
of longer-term dietary fatty acid intake (~120 days) 
(Arab, 2003). 
Results  of  some  cross-sectional  studies  that 
investigated  the  correlation  between  erythrocyte 
membrane fatty acid composition and insulin sensi-
tivity (Agostoni et al., 1994; Clifton and Nestel, 1998; 
Enriquez  et  al.,  2004;  Rodriguez  and  Christophe, 
2005) indicate that this relation may differ, depend-
ing on the type of population studied. Clifton and 
Nestel (1998) found an inverse relationship between 
fasting plasma insulin and the erythrocyte percent-
age  of  arachidonic  acid  (AA,  20:4n-6)  and  total 
n-6 PUFAs, and a positive relationship between it 
and the percentage of SFAs in healthy men (Clifton 
and Nestel, 1998). In obese type 2 diabetics receiv-
ing metformin therapy, different relationships were 
observed: the fasting insulin level correlated posi-
tively with alpha-linolenic (18:3n-3) and dihomo-
gamma-linolenic  (20:3n-6)  acids  and  negatively 
with the fraction of palmitic acid (16:0) in erythro-
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cyte phospholipids (Enriquez et al., 2004). 
The effects of n-3 long-chain PUFAs on insu-
lin sensitivity in humans also need to be clarified, 
as  some  n-3  LC-PUFA  supplementation  studies 
reported  a  beneficial  effect  (Pop-Snijders  et  al., 
1987) and others a lack of effects on insulin sensitiv-
ity (Brady et al., 2004), and this variability may also 
be related to metabolic characteristics of the study 
population (Browning, 2003). It could be important 
to investigate a population on a typical Serbian diet, 
with high intake of SFAs and low intake of PUFAs, 
especially ones of the n-3 PUFA family (Simopoulos, 
2005).
To the best of our knowledge, there are no pub-
lished reports on the relationship between erythro-
cyte fatty acid composition and insulin sensitivity in 
nondiabetic, normoglycemic, and overweight/obese 
subjects with hyperlipidemia. There is very limited 
information about the FA intake of patients on a typ-
ical Serbian diet and related health consequences. 
Using membrane fatty acid composition as an objec-
tive index of dietary fatty acid intake, we obtained 
results in a cross-sectional study that may aid the 
planning of nutritional strategies designed to pre-
vent the development of type 2 diabetes in obesity. 
MATERIALS AND METHODS
Subjects
A total of 30 free-living overweight/obese patients 
were selected on the basis of the following criteria: 
body mass index (BMI) greater than 25 kg/m2 and 
weight  stable  (±  2  kg)  for  6  months  prior  to  the 
beginning of the study; normal fasting glucose lev-
els according to World Health Organization criteria 
(fasting glucose < 6.1 mmol/l); hyperlipidemia, as 
defined  by  total  serum  cholesterol  ≥  5.2  mmol/l, 
serum LDL-cholesterol ≥ 3.4 mmol/l, and normal 
or increased triglyceride levels (the lipid status was 
based on data from two fasting serum lipid profiles). 
Exclusion criteria were: hepatic dysfunction; renal 
dysfunction;  uncontrolled  hypertension;  hypo-  or 
hyperthyroidism; unstable angina pectoris; myocar-
dial infarction within the previous 6 months; and 
alcohol consumption. None of the eligible subjects 
used any lipid-lowering drugs, immunosuppressive 
agents,  anticoagulants,  hormone  substitutes,  beta-
blockers,  or  anti-platelet  aggregation  medications 
for 12 weeks prior to the start of the study. All of 
the subjects were free-living on their habitual diet, 
typical of the Serbian population, with low fish and 
soy consumption (one meal in two weeks) and high 
animal fat intake (they consumed meat, eggs, and 
whole milk products every day). They engaged in 
low regular physical activity (light physical exertion 
such  as  walking  or  biking  for  less  than  2  hours/
week). None of the patients had a family history of . None of the patients had a family history of  None of the patients had a family history of 
diabetes mellitus.
All  patients  signed  an  informed  consent  doc-
ument;  the  study  was  approved  by  the  Medical 
Ethics Committee (Institute for Medical Research, 
Belgrade) and conducted according to principles of 
good scientific practice.
Methods
Body weight was measured on a balance calibrated 
to 0.1 kg. Standing height was measured barefoot to 
the nearest 0.5 cm using a wall-mounted statiometer. 
All measurements were obtained after an overnight 
fast of at least 12 h. 
The fasting serum insulin level and homeostasis 
model assessment (HOMA) values were selected as 
insulin resistance markers. The HOMA value was 
calculated as the fasting glucose level (mmol/l) x the 
fasting insulin level (mU/l)/22.5. A HOMA value > 
2.5 was considered indicative of insulin resistance, 
as suggested in the Bruneck study (Bonora et al., 
1998). Using the HOMA value, we formed two insu-
lin  sensitivity  groups:  a  normal  glucose  tolerance 
(HOMA value < 2.5) or NGT group; and an insulin 
resistance (HOMA value > 2.5) or IR group of over-
weight/obese patients with hyperlipoproteinemia. 
Glucose, total cholesterol, and triglyceride levels 
were measured in serum after a 12-h fast using enzy-
matic  methods  with  glucose  oxidase,  cholesterol 
oxidase, and glycerol oxidase, respectively (EliTech 
Diagnostic,  Sées,  France).  HDL-Cholesterol  was 
determined in the supernatant liquid after precipi-
tation  with  phosphotungstic  acid  and  magnesium 
chloride. LDL-Cholesterol was estimated using the 
Friedewald  formula.  The  serum  insulin  level  was INsulIN seNsItIvIty IN obese patIeNts 39
determined  with  a  radioimmunoassay  kit  (INEP, 
Zemun, Serbia). 
Red  blood  cell  lipids  were  extracted  by  the 
method of Harth (Harth et al., 1978). The eryth-
rocyte phospholipid fraction was isolated by one-
dimensional  thin-layer  chromatography  (TLC)  in 
a neutral hexane-diethyl ether-acetic acid (87:12:1; 
v/v/v) solvent system using silica gel GF plates (C. 
Merck, Darmstadt, Germany). Following methyla-
tion, fatty acid ester derivates were analyzed by gas 
chromatography using a Varian gas chromatograph 
(model  3400).  Individual  fatty  acid  methyl  esters 
were identified using a fatty acid standard mixture 
(PUFA-2, Sigma, Germany). The share of 18:3 n-3 
was too low to be detected and was not included in 
the sum of n-3 PUFA.
Statistical analyses
All results are expressed as a means±SD. Differences 
between the formed groups were analyzed using the 
unpaired  Student’s  t-test,  accepting  an  alpha  sig-
nificance level of p ≤ 0.05. Pearson correlation coef-
ficients were computed for examining the relations 
between BMI, insulin, HOMA value, and erythro-
cyte fatty acid concentrations. 
Abbreviations — FA – fatty acid; LDL – low-density 
lipoproteins; HOMA – homeostasis model assess-
ment; NGT – normal glucose tolerance; IR – insulin 
resistance; TLC – thin-layer chromatography; PUFA 
–  polyunsaturated  fatty  acids;  BMI  –  body  mass 
index;  SFA  –  saturated  fatty  acids;  AA  –  arachi-
donic acid; HDL – high-density lipoproteins; MUFA 
– monounsaturated fatty acids; LC-PUFA – long-
chain polyunsatured fatty acids.
RESULTS
The  mean  clinical  and  metabolic  parameters  are 
shown in Table 1. The BMI ranged from 26 to 45 
kg/m2, serum fasting insulin from 9.1 to 31.2 mU/
ml, and fasting glucose from 3.92 to 5.24 mmol/l. No 
differences of lipid parameters were found between 
groups.  In  the  IR  group,  the  fasting  insulin  level 
(20.1±6.0  mU/ml)  was  higher  than  in  the  NGT 
group (10.8±1.3 mU/ml) (p < 0.001). The BMI value 
was also significantly higher in the IR group (p < 
0.05).
Results on erythrocyte phospholipid fatty acid 
composition are shown in Table 2. Levels of 22:5n-3 
(p < 0.01), 22:6n-3 (p < 0.01), and total n-3 PUFAs (p 
< 0.001) were lower in the IR group than in the NGT 
group. Higher n-6 PUFA/n-3 PUFA, SFA/n-3 PUFA, 
and MUFA/n-3 PUFA ratios were also observed in 
IR patients compared to the NGT group of patients 
(p < 0.01). There was no difference in the percentage 
of individual or total n-6 PUFAs between groups, 
although the ratio between arachidonic acid (20:4n-
Table 1. Clinical and biochemical data for all subjects grouped in glucose tolerance categories. All data represented as means±SE. 
*p < 0.05; ***p < 0.001 compared to NGT group.
all patients
n=30
NGT group
n=12
IR group
n=18
age (years) 56±12 58±9 54±14
male/female 7/23 2/10 5/13
BMI (kg/m2) 32.9±5.0 30.3±2.4 34.7±5.6*
fasting glucose (mmol/l) 4.76±0.50 4.63±0.54 4.84±0.46
triglycerides (mmol/l) 2.15±0.99 2.21±1.03 2.12±1.00
total cholesterol (mmol/l) 7.62±1.02 7.51±1.06 7.68±1.02
LDL-cholesterol (mmol/l) 5.28±1.06 5.16±1.11 5.35±1.05
HDL-cholesterol (mmol/l) 1.32±0.13 1.34±0.14 1.30±0.13
fasting insulin (mU/ml) 16.4±6.6 10.8±1.3 20.1±6.0***
HOMA value  3.50±1.63 2.21±0.6 4.37±1.58***M. TAKIĆ ET AL. 40
Table 2. Erythrocyte fatty acid composition for all subjects grouped in glucose tolerance categories. All data represented as means±SE. 
Fatty acid concentration is expressed in % of totally detected fatty acids. SFA – saturated fatty acids, MUFA – monounsaturated fatty 
acids, PUFA – polyunsaturated fatty acids. *p < 0.05; **p < 0.01; ***p < 0.001 compared to NGT group.
all patients
n=30
NGT group
n=12
IR group
n=18
16:0 22.63±1.39 22.49±1.67 22.73±1.21
18:0 18.77±2.08 18.25±1.07 19.11±2.51
SFA 41.40±2.54 40.74±1.73 41.83±2.93
16:1n-7 0.31±0.11 0.29±0.13 0.33±0.10
18:1n-9 16.78±1.29 16.30±0.71 17.10±1.50
MUFA 17.10±1.05 16.59±0.81 17.44±1.55
18:2n-6 12.66±1.69 12.20±1.60 12.97±1.73
20:3n-6 1.85±0.42 1.68±0.32 1.96±0.44
20:4n-6 16.67±1.92 17.29±1.73 16.26±1.98
22:4n-6 3.83±0.72 3.85±0.75 3.82±0.72
n-6 35.1±2.98 35.02±2.36 35.01±3.40
20:5n-3 0.43±0.23 0.51±0.23 0.38±0.22
22:5n-3 1.71±0.39 1.97±0.43     1.55±0.26**
22:6n-3 4.33±1.25 5.17±1.29     3.77±0.86**
n-3 6.48±1.70 7.65±1.70       5.69±1.19***
PUFA 41.49±3.18 42.67±1.91 40.70±3.63
n-6/n-3 5.77±1.56 4.86±1.41       6.38±1.37**
SFA/PUFA 1.01±0.14 0.96±0.08   1.04±0.17
SFA/n-6 1.20±0.17 1.17±0.13   1.21±0.20
SFA/n-3 6.83±1.85 5.61±1.51       7.65±1.61**
MUFA/PUFA 0.42±0.06 0.39±0.03   0.43±0.07
MUFA/n-6 0.49±0.07 0.48±0.04   0.50±0.09
MUFA/n-3 2.84±0.83 2.31±0.72       3.19±0.72**
SFA/MUFA 2.43±0.20 2.46±0.16   2.41±0.23
20:4/20:3 9.44±2.32 10.67±2.28     8.63±2.03*
C20-22 28.83±2.80 30.26±1.96     27.74±2.80**
Table 2. Pearson correlation coefficients between insulin resistance markers and erythrocyte fatty acid percentages.
insulin (mU/ml) HOMA value BMI (kg/m2)
R P r P r P
20:5n-3 - 0.34  0.062 - 0.31  0.093 - 0.40  0.057
22:5n-3 - 0.42 < 0.05 - 0.41 < 0.05 - 0.40 < 0.05
22:6n-3 - 0.51 < 0.01 - 0.46 < 0.01 - 0.30  0.089
n-3 - 0.52 < 0.01 - 0.47 < 0.01 - 0.40 < 0.05INsulIN seNsItIvIty IN obese patIeNts 41
6) and dihomo-gamma linolenic acid (20:3n-6), as a 
measure of ∆5 desaturase activity, was significantly 
lower in the IR group (p < 0.05). 
A positive correlation was discovered between 
the fasting insulin level and the resistance param-
eter  (HOMA  value)  and  BMI  (r  =  0.60  and  r  = 
0.58,  respectively;  p  <  0.001).  Correlations  were 
determined between insulin resistance parameters 
(the fasting insulin level and HOMA value), BMI, 
and the percentage of erythrocyte n-3 PUFAs (Table 
3). The fasting insulin level and HOMA value were 
inversely related to the percentage of 22:5n-3 (p < 
0.05) and 22:6n-3 (p < 0.01) individual fatty acids, 
as well as total n-3 (p < 0.01). In erythrocyte mem-
brane phospholipids, a negative correlation was also 
found between BMI and the percentage of 22:5n-3 
(p < 0.05) and total n-3 PUFAs (p < 0.01).
DISCUSSION
We  have  demonstrated  that  membrane  fatty  acid 
composition is related to insulin sensitivity in over-
weight/obese patients with hyperlipidemia. Our data 
indicate a previously unreported strong correlation 
between erythrocyte phospholipid n-3 PUFA levels 
and insulin sensitivity in obesity. Since erythrocyte 
fatty acid composition reflects dietary essential FA 
intake,  this  suggests  that  increased  PUFA  intake, 
especially uptake of long-chain n-3 PUFAs, could 
provide a simple mechanism for increased insulin 
responsiveness in obese patients on a typical Serbian 
diet low in n-3 PUFAs. 
Since a measure of ∆5 desaturase activity (the 
ratio of 20:4n-6 to 20:3n-6) was lower in the IR com-
pared to the NGT group, it follows that alteration of 
fatty acid metabolism is a factor related to insulin 
responsiveness in our study. Similar results indicat-
ing association of insulin action with ∆5 desaturase 
activity  have  previously  been  reported  in  healthy 
individuals, type 2 diabetic patients, and type 1 dia-
betic patients (Tilvis and Miettinen, 1985; Clifton 
and Nestel, 1998; Rodriguez and Christophe, 2005).
The effects of long-chain (LC) n-3 PUFAs on 
insulin sensitivity were mostly evaluated in human 
studies. Beneficial effects of n-3 LC-PUFA supple-
mentation  on  insulin  sensitivity  were  reported  in 
some patient groups (diabetic patients, persons with 
impaired  glucose  tolerance),  but  positive  effects 
were not observed in others (healthy subjects) (Pop-
Snijders et al., 1987; Brady et al., 2004). In studies 
that  investigated  the  relation  between  erythrocyte 
fatty  acid  composition  and  insulin  sensitivity,  no 
correlation was found between the erythrocyte per-
centage  of  n-3  PUFAs  and  fasting  insulin  levels 
in  healthy  individuals  and  non-obese  type  2  dia-
betic patients (Enriquez et al., 2004; Rodriguez and 
Christophe, 2005), although the erythrocyte 20:5n-3 
level  was  negatively  correlated  with  insulin  levels 
in obese children (Agostoni et al., 1994). Haugaard 
et al. (2006) examined the impact of a hypocaloric 
low-fat dietary intervention on membrane fatty acid 
composition  and  insulin  sensitivity.  They  found 
that skeletal muscle long-chain n-3 PUFAs were an 
independent  predictor  of  HOMA  values  in  obese 
subjects (Haugaard et al., 2006).
Differences in the share of n-3 PUFAs in eryth-
rocyte  phospholipids  between  the  NGT  and  IR 
groups were demonstrated in our study for obese 
patients with increased LDL-cholesterol levels. We 
also found that the percentage of some long-chain n-
3 PUFAs was in negative correlation with the fasting 
insulin level and HOMA value, as well as with BMI.
Our results show that the erythrocyte membrane 
n-3 PUFA level and insulin sensitivity are linked in 
obese patients with high LDL-cholesterol levels on a 
typical Serbian diet. Since erythrocyte phospholipid 
n-3 PUFA levels are also correlated with BMI, it fol-
lows that characteristics of the population studied 
may by highly significant for the effect of n-3 PUFAs 
on insulin sensitivity. Our results suggest that the 
erythrocyte membrane n-3 PUFA status could be an 
important factor determining the influence of n-3 
PUFA supplementation on insulin resistance. 
A major finding of our cross-sectional study was 
the inverse relationship observed in the studied pop-
ulation group between erythrocyte n-3 PUFA levels 
and insulin sensitivity, which could be a character-
istic of obesity and low dietary n-3 PUFA intake. 
Since erythrocyte phospholipid fatty acid composi-
tion can be modified with dietary long-chain n-3 M. TAKIĆ ET AL. 42
PUFAs, their increased intake could be a beneficial 
nutritional measure in preventing the development 
of type 2 diabetes in overweight/obese patients on a 
typical Serbian diet suffering from hyperlipidemia 
accompanied by high LDL-cholesterol levels (even if 
their triglyceride levels are not increased). 
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Маснокиселински састав мембрана, који се бар 
делимичﾭно може модификовати дијетарним уно-
сом масних киселина, игра важну улогу у сензитив-
ности на инсулин. Циљ ове студије био је испитива-
ње везе између сензитивности на инсулин и масно-
киселинског састава фосфолипида еритроцита код 
гојазних  особа.  Тридесет  умерено  гојазних/гоја-
зних недијабетичﾭара са хиперлипопротеинемијама 
(укупни холестерол > 5.2 mmol/l, LDL-холестерол 
> 3.4 mmol/l) подељени су у две групе, користећи 
HOMA вредност као параметар сензитивности на 
инсулин: групу са нормалном толеранцом на глу-
козу (NTG) и групу са резистенцијом на инсулин 
(IR). Укупни липиди еритроцита су естраховани 
и  фосфолипиди  изоловани  танкослојном  хрома-
тографијом.  После  метиловања  масне  киселине 
анализиране  су  гасно-течﾭном  хроматографијом. 
Заступљеност 22:5n-3 (p < 0.01), 22:6n-3 (p < 0.01), 
укупних  n-3  полинезасићених  масних  киселина 
(p < 0.001) и однос заступљености 20:4n-6/20:3n-6 
(показатеља активности делта-5 десатуразе) (p < 
0.05) су снижени у IR групи у поређењу са NGT гру-
пом. Ниво инсулина наташте и HOMA вредност 
инвернтно су повезани са заступљеношћу 22:5n-3 
(p < 0.05), 22:6n-3 (p < 0.01) и укупним n-3 полине-
засићеним киселинама (p < 0.01). Наши резултати 
показују да је ниво n-3 масних киселина у фосфоли-
пидима еритроцита повезан са сензитивношћу на 
инсулин код гојазних особа на исхрани типичﾭној 
за поднебље Србије.